Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial peptidoglycan beta-1,4-glycosidic bond is the fundamental chemical linkage that connects N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) residues within the glycan strands of the bacterial cell wall [1]. This bond is essential for maintaining the structural integrity and rigidity of the peptidoglycan sacculus, which protects the bacterium from bursting due to internal osmotic pressure [2]. As a primary target of the innate immune system, this bond is hydrolyzed by lysozyme (muramidase), an enzyme found in human secretions such as tears and saliva [3]. The cleavage of these bonds results in the degradation of the cell wall, leading to bacterial lysis and death, particularly in Gram-positive species where the peptidoglycan layer is more accessible [1]. In therapeutic contexts, this bond is the target of purified lysozyme used as a food preservative or pharmaceutical, as well as engineered bacteriophage endolysins currently under development as enzybiotics to treat multi-drug resistant infections [4]. Understanding the stability and enzymatic susceptibility of this bond is crucial for developing new classes of antibacterials that bypass traditional antibiotic resistance mechanisms [2]. [1] Vollmer, W., et al. (2008). FEMS Microbiol Rev. [2] Silhavy, T. J., et al. (2010). Cold Spring Harb Perspect Biol. [3] Ragland, S. A., & Criss, A. K. (2017). PLoS Pathog. [4] Schmelcher, M., et al. (2012). Future Microbiol.
Enzymatic hydrolysis of the beta-1,4-glycosidic linkage between N-acetylmuramic acid and N-acetylglucosamine, which disrupts the glycan backbone of the bacterial cell wall, leading to loss of structural integrity and osmotic lysis.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial peptidoglycan beta-1,4-glycosidic bond.